Formulation Design and Discriminatory Dissolution Method Development of Controlled-release Tablets of Apremilast Solid Dispersion for Once a Day Administration: a QbD Approach

Journal of Pharmaceutical Innovation · Published 2026-08-01 · DOI 10.1007/s12247-026-10805-6

Authors (5)

Sandipan Roy, Apoorva Phadke, Nehal Sarvaiya, Vaishali Londhe, Sujata Sawarkar

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Roy, S., Phadke, A., Sarvaiya, N., et al. (2026). Formulation Design and Discriminatory Dissolution Method Development of Controlled-release Tablets of Apremilast Solid Dispersion for Once a Day Administration: a QbD Approach. Journal of Pharmaceutical Innovation. https://doi.org/10.1007/s12247-026-10805-6

Related articles

• Quality-by-design Assisted Laboratory Scale Up of Artemisinin Nanoemulsion Augmented Drug Delivery, Cytotoxicity and Cellular Uptake in Leishmania donovani Parasite, a Causative Agent for Cutaneous Leishmaniasis · Journal of Pharmaceutical Innovation · 2026 · Same journal
• Smart/Stimuli-Responsive Hydrogels: Cutting-Edge Delivery Cargoes for Tissue Engineering Applications · Journal of Pharmaceutical Innovation · 2026 · Same journal
• Indazole-Based Small Molecules as Cyclin-Dependent Kinase-2 Inhibitors: Synthesis, In Vitro Anticancer Evaluation, and Molecular Docking Studies · Journal of Pharmaceutical Innovation · 2026 · Same journal
• Comparative Analysis of Polymeric and Lipid Polymer Hybrid Nanoparticles: In-Vitro and In-Vivo Analysis for Pulmonary Delivery of Atorvastatin · Journal of Pharmaceutical Innovation · 2026 · Same journal
• Self-Assembled Dextran-Stearic Acid Nanocarrier for Co-Delivery of Temozolomide and IFN-α with Enhanced in Vitro Antitumor Activity in Melanoma Cells · Journal of Pharmaceutical Innovation · 2026 · Same journal
• Synergistic Anticancer effects of Fagonia indica Extract in Combination with Paclitaxel and Benzoporphyrin Derivative · Journal of Pharmaceutical Innovation · 2026 · Same journal
• Umbilical MSC-Derived Exosome-Associated Standardized Propolis Polyphenols Enhance Apoptosis-Associated and Oxidant-Responsive Signals in HepG2 Cells · Journal of Pharmaceutical Innovation · 2026 · Same journal
• Linalool-Linalyl Acetate as a Non-steroidal Alternative to Mometasone-Salicylic Acid Therapy in Imiquimod-induced Psoriasis Model · Journal of Pharmaceutical Innovation · 2026 · Same journal
• Mechanistic Insights into LGALS3-Mediated Osteoarthritis Progression: Activation of the cGAS-STING Pathway as a Key Driver of Senescence-Related Osteoarthritis · Journal of Pharmaceutical Innovation · 2026 · Same journal
• Box-Behnken Design (BBD) Based Development of Naringenin Encapsulated Transferosome Infused In Situ Gel for Wound Healing: Safety Study, Efficacy Assessment and In Vitro Evaluation · Journal of Pharmaceutical Innovation · 2026 · Same journal